GSK

GSK · LSE · GBp

1,779.50 GBp−0.86%−15.50 GBp

Close · October 2, 2026

At a glance

Revenue growth
+4.11%
2025 vs 2024
Net income growth
+121.98%
2025 vs 2024
Net margin
17.5%
2024: 8.2%

Financial data

Amounts in millions of GBP; per-share values in GBP; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total revenue8,4097,6298,6188,5477,9867,5168,1178,0127,8847,3638,0528,147
Cost of revenue2,0721,8732,6172,2392,1651,9262,5372,3282,0621,9182,3372,243
Gross profit6,3375,7566,0016,3085,8215,5905,5805,6845,8225,4455,7155,904
Selling, general and administrative2,1922,0852,6662,1622,1312,0542,6213,7672,3892,0702,5952,212
Research and development1,7471,5182,1381,5751,5441,3971,8361,4411,4281,3731,7991,448
Operating income2,6022,7681,6313,0822,3922,3101,0036672,1492,3051,7212,765
EBIT2,6022,7681,6313,0822,3922,3101,0036672,1492,3051,7212,765
EBITDA2,8253,2312,6893,8203,0113,1331,8491,6182,7882,8541,9513,344
Interest expense182167145167184162120155174166146180
Pre-tax income3542,1449502,4561,8872,10856364.01,4951,3553791,791
Income tax-19930522331224133662.0-1.0191274-19.0257
Net income4351,7376362,0131,4431,624414-58.01,1731,0463501,464
Net income to common shareholders4351,7376362,0131,4431,624414-58.01,1731,0463501,464
Basic EPS0.110.430.160.500.360.400.10-0.010.290.260.090.36
Diluted EPS0.110.430.160.490.350.390.10-0.010.290.250.090.36
Average shares (basic)4,0144,0234,0194,0344,0634,0884,0814,0804,0794,0694,0564,055
Average shares (diluted)4,0624,0744,0864,1024,1104,1374,1454,1414,1224,1134,1164,112
Dividend per share0.170.170.180.160.160.160.160.150.150.150.160.14